These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 14577443

  • 21. Exploring the potential link between Medicaid access restrictions, physician location, and health disparities.
    Headen A, Masia N.
    Am J Manag Care; 2005 Jan; 11 Spec No():SP21-6. PubMed ID: 15700906
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Drug utilization review: mechanisms to improve its effectiveness and broaden its scope. The U.S. Pharmacopeia Drug Utilization Review Advisory Panel.
    J Am Pharm Assoc (Wash); 2000 Jan; 40(4):538-45. PubMed ID: 10932464
    [Abstract] [Full Text] [Related]

  • 24. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS, Miller GE.
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [Abstract] [Full Text] [Related]

  • 25. Pharmacists' reactions to the Wisconsin Medicaid drug-use review program.
    Brown CM, Lipowski EE.
    Am J Hosp Pharm; 1993 Sep; 50(9):1898-902. PubMed ID: 7907839
    [Abstract] [Full Text] [Related]

  • 26. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM, Rebelein RP, Heaton PC, Ferrand Y, Guo JJ.
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [Abstract] [Full Text] [Related]

  • 27. Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental study.
    Grégoire JP, Moisan J, Potvin L, Chabot I, Verreault R, Milot A.
    BMC Health Serv Res; 2006 Mar 14; 6():33. PubMed ID: 16536865
    [Abstract] [Full Text] [Related]

  • 28. Using clinical evidence to manage pharmacy benefits: experiences of six states.
    Bergman D, Hoadley J, Kaye N, Crowley J, Hostetter M.
    Issue Brief (Commonw Fund); 2006 Mar 14; (899):1-14. PubMed ID: 16562357
    [Abstract] [Full Text] [Related]

  • 29. States' control of prescription drug spending: a heterogeneous approach.
    Morden NE, Sullivan SD.
    Health Aff (Millwood); 2005 Mar 14; 24(4):1032-8. PubMed ID: 16012143
    [Abstract] [Full Text] [Related]

  • 30. Michigan drug utilization review and OBRA 90.
    Sandusky M.
    Mich Med; 1993 Apr 14; 92(4):38-9. PubMed ID: 8231930
    [Abstract] [Full Text] [Related]

  • 31. Cluster analysis of state Medicaid prescription drug benefit programs based on potential determinants of per capita drug expenditure.
    Roy S, Madhavan SS.
    Res Social Adm Pharm; 2009 Mar 14; 5(1):51-62. PubMed ID: 19285289
    [Abstract] [Full Text] [Related]

  • 32. Administrative and claims records as sources of health care cost data.
    Riley GF.
    Med Care; 2009 Jul 14; 47(7 Suppl 1):S51-5. PubMed ID: 19536019
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of a DUR intervention: a case study of histamine antagonists.
    Zimmerman DR, Collins TM, Lipowski EE, Sainfort F.
    Inquiry; 1994 Jul 14; 31(1):89-101. PubMed ID: 7909535
    [Abstract] [Full Text] [Related]

  • 34. Watching the monitors: "PAID" prescriptions, fiscal intermediaries and drug-utilization review.
    Morgan JP.
    N Engl J Med; 1977 Feb 03; 296(5):251-6. PubMed ID: 318733
    [Abstract] [Full Text] [Related]

  • 35. Drug utilization: using objective data to achieve cost-efficiency.
    Eber BL.
    Benefits Q; 2005 Feb 03; 21(1):7-13. PubMed ID: 15825631
    [Abstract] [Full Text] [Related]

  • 36. Retrospective drug utilization review, prescribing errors, and clinical outcomes.
    Hennessy S, Bilker WB, Zhou L, Weber AL, Brensinger C, Wang Y, Strom BL.
    JAMA; 2003 Sep 17; 290(11):1494-9. PubMed ID: 13129990
    [Abstract] [Full Text] [Related]

  • 37. Comparing the Medicaid Retrospective Drug Utilization Review Program Cost-Savings Methods Used by State Agencies.
    Prada SI.
    Am Health Drug Benefits; 2017 Dec 17; 10(9):477-482. PubMed ID: 29403573
    [Abstract] [Full Text] [Related]

  • 38. Changes in drug utilization for seniors without prior prescription drug insurance.
    Hudson N.
    Find Brief; 2009 Mar 17; 12(2):1-3. PubMed ID: 19297802
    [Abstract] [Full Text] [Related]

  • 39. Variability in prescription drug utilization: issues for research.
    Anis AH, Carruthers SG, Carter AO, Kierulf J.
    CMAJ; 1996 Mar 01; 154(5):635-40. PubMed ID: 8603319
    [Abstract] [Full Text] [Related]

  • 40. Analysis of anti-epileptic drugs in fee-for-service Wisconsin Medicaid.
    Mergener MA, Carr RM.
    WMJ; 2006 Sep 01; 105(6):36-9. PubMed ID: 17042418
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.